4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-17-001163
$NBYCIK 0001389545operating
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:48 PM ET
Size
5.2 KB
Accession
0001437749-17-001163
Insider Transaction Report
Form 4
Hall Justin
General Counsel
Transactions
- Award
stock option (right to buy)
2017-01-25+143,000→ 278,160 totalExercise: $3.60From: 2018-01-31Exp: 2027-01-25→ Common Stock (143,000 underlying)
Footnotes (2)
- [F1]Options granted pursuant to 2007 Omnibus Incentive Plan
- [F2]the Option will vest on January 31, 2018, in direct proportion to the percentage achievement of the stated 2017 corporate goals, as approved and determined by the Board.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 6:48 PM ET
- Size
- 5.2 KB